Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB

Background: Breast cancer cells can develop chemoresistance after prolonged exposure to cytotoxic drugs due to expression of the multi drug resistance (MDR) 1 gene. Type 2 cyclo-oxygenase (COX-2) inhibitors reverse the chemoresistance phenotype of a medullary thyroid carcinoma cell line, TT, and of...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Chiara Zatelli, Daniela Molè, Federico Tagliati, Mariella Minoia, Maria Rosaria Ambrosio, Ettore Degli Uberti
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.3233/CLO-2009-0490
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691784515420160
author Maria Chiara Zatelli
Daniela Molè
Federico Tagliati
Mariella Minoia
Maria Rosaria Ambrosio
Ettore Degli Uberti
author_facet Maria Chiara Zatelli
Daniela Molè
Federico Tagliati
Mariella Minoia
Maria Rosaria Ambrosio
Ettore Degli Uberti
author_sort Maria Chiara Zatelli
collection DOAJ
description Background: Breast cancer cells can develop chemoresistance after prolonged exposure to cytotoxic drugs due to expression of the multi drug resistance (MDR) 1 gene. Type 2 cyclo-oxygenase (COX-2) inhibitors reverse the chemoresistance phenotype of a medullary thyroid carcinoma cell line, TT, and of a breast cancer cell line, MCF7, by inhibiting MDR1 expression and P-gp function.
format Article
id doaj-art-e0450d1c8ea648b998382daa483a8bf3
institution DOAJ
issn 1570-5870
1875-8606
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-e0450d1c8ea648b998382daa483a8bf32025-08-20T03:20:56ZengWileyCellular Oncology1570-58701875-86062009-01-0131645746510.3233/CLO-2009-0490Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κBMaria Chiara Zatelli0Daniela Molè1Federico Tagliati2Mariella Minoia3Maria Rosaria Ambrosio4Ettore Degli Uberti5Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, ItalySection of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, ItalySection of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, ItalySection of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, ItalySection of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, ItalySection of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, ItalyBackground: Breast cancer cells can develop chemoresistance after prolonged exposure to cytotoxic drugs due to expression of the multi drug resistance (MDR) 1 gene. Type 2 cyclo-oxygenase (COX-2) inhibitors reverse the chemoresistance phenotype of a medullary thyroid carcinoma cell line, TT, and of a breast cancer cell line, MCF7, by inhibiting MDR1 expression and P-gp function.http://dx.doi.org/10.3233/CLO-2009-0490
spellingShingle Maria Chiara Zatelli
Daniela Molè
Federico Tagliati
Mariella Minoia
Maria Rosaria Ambrosio
Ettore Degli Uberti
Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB
Cellular Oncology
title Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB
title_full Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB
title_fullStr Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB
title_full_unstemmed Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB
title_short Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB
title_sort cyclo oxygenase 2 modulates chemoresistance in breast cancer cells involving nf κb
url http://dx.doi.org/10.3233/CLO-2009-0490
work_keys_str_mv AT mariachiarazatelli cyclooxygenase2modulateschemoresistanceinbreastcancercellsinvolvingnfkb
AT danielamole cyclooxygenase2modulateschemoresistanceinbreastcancercellsinvolvingnfkb
AT federicotagliati cyclooxygenase2modulateschemoresistanceinbreastcancercellsinvolvingnfkb
AT mariellaminoia cyclooxygenase2modulateschemoresistanceinbreastcancercellsinvolvingnfkb
AT mariarosariaambrosio cyclooxygenase2modulateschemoresistanceinbreastcancercellsinvolvingnfkb
AT ettoredegliuberti cyclooxygenase2modulateschemoresistanceinbreastcancercellsinvolvingnfkb